The Drug Supply Chain Security Act (DSCSA) revolutionizes drug recalls by requiring electronic traceability of prescription drugs. This enables faster, more accurate responses, reducing risks to patients and ensuring safer, data-driven recall processes. As the 2025 and 2026 deadlines approach, pharmacies and supply chain stakeholders must prioritize interoperability to leverage these advancements and improve patient safety.